| Literature DB >> 29434545 |
Abstract
Background: Since the early 2010s, the neuroimaging field has paid more attention to the issue of false positives. Several journals have issued guidelines regarding statistical thresholds. Three papers have reported the statistical analysis of the thresholds used in fMRI literature, but they were published at least 3 years ago and surveyed papers published during 2007-2012. This study revisited this topic to evaluate the changes in this field.Entities:
Keywords: Gaussian random field; Monte Carlo stimulation; fMRI; false-discovery rate; familywise error rate; literature; threshold; threshold-free cluster enhancement
Year: 2018 PMID: 29434545 PMCID: PMC5790797 DOI: 10.3389/fnhum.2018.00016
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Recently published recommended statistical practices for controlling false positives.
| Publication name | Recommendations |
|---|---|
| 1. Set the default cluster-defining primary threshold (CDT) at | |
| 1. The parametric method works well for voxelwise inferences but not for clusterwise inferences (unless a stringent CDT is set at | |
| 1. For clusterwise inferences, choose a stringent CDT (e.g., | |
| 1. Studies investigating very small brain regions should use a high voxel threshold (e.g., |
The 125 journals that published the 388 analyzed articles.
| Journal list | Count | % | Journal list (continued) | Count | % |
|---|---|---|---|---|---|
| Neuroimage | 23 | 5.9 | Alzheimers Dement (Amst) | 1 | 0.3 |
| Cortex | 14 | 3.6 | Appl Neuropsychol Child | 1 | 0.3 |
| Neuropsychologia | 14 | 3.6 | Arch Gerontol Geriatr | 1 | 0.3 |
| Brain Imaging Behav | 13 | 3.4 | Behav Res Ther | 1 | 0.3 |
| Cereb Cortex | 13 | 3.4 | BMC Psychiatry | 1 | 0.3 |
| Hum Brain Mapp | 13 | 3.4 | Br J Psychiatry | 1 | 0.3 |
| J Neurosci | 12 | 3.1 | Br J Sports Med | 1 | 0.3 |
| PloS One | 12 | 3.1 | Cerebellum | 1 | 0.3 |
| Sci Rep | 12 | 3.1 | Cogn Neurosci | 1 | 0.3 |
| J Cogn Neurosci | 11 | 2.8 | Cultur Divers Ethnic Minor Psychol | 1 | 0.3 |
| Behav Brain Res | 10 | 2.6 | Dev Psychol | 1 | 0.3 |
| Psychiatry Res | 9 | 2.3 | Einstein (Sao Paulo) | 1 | 0.3 |
| J Affect Disord | 8 | 2.1 | Emotion | 1 | 0.3 |
| Neuroimage Clin | 8 | 2.1 | Epilepsy Behav | 1 | 0.3 |
| Brain Struct Funct | 6 | 1.5 | Eur Child Adolesc Psychiatry | 1 | 0.3 |
| Neuroscience | 6 | 1.5 | Eur Eat Disord Rev | 1 | 0.3 |
| Soc Cogn Affect Neurosci | 6 | 1.5 | Eur J Paediatr Neurol | 1 | 0.3 |
| Addict Biol | 5 | 1.3 | Eur J Pain | 1 | 0.3 |
| Biol Psychol | 5 | 1.3 | Eur Neuropsychopharmacol | 1 | 0.3 |
| Dev Psychopathol | 5 | 1.3 | Eur Radiol | 1 | 0.3 |
| Neuropsychopharmacology | 5 | 1.3 | Front Aging Neurosci | 1 | 0.3 |
| Psychol Med | 5 | 1.3 | Front Neuroanat | 1 | 0.3 |
| Soc Neurosci | 5 | 1.3 | Front Psychol | 1 | 0.3 |
| Addiction | 4 | 1 | Int J Neuropsychopharmacol | 1 | 0.3 |
| Brain Cogn | 4 | 1 | Int J Neurosci | 1 | 0.3 |
| Brain Res | 4 | 1 | Int J Psychophysiol | 1 | 0.3 |
| Cogn Affect Behav Neurosci | 4 | 1 | J Alzheimers Dis | 1 | 0.3 |
| Dev Sci | 4 | 1 | J Am Acad Child Adolesc Psychiatry | 1 | 0.3 |
| Eur J Neurosci | 4 | 1 | J Atten Disord | 1 | 0.3 |
| Front Behav Neurosci | 4 | 1 | J Autism Dev Disord | 1 | 0.3 |
| Front Hum Neurosci | 4 | 1 | J Child Sex Abus | 1 | 0.3 |
| Mult Scler | 4 | 1 | J Clin Exp Neuropsychol | 1 | 0.3 |
| Transl Psychiatry | 4 | 1 | J Hypertens | 1 | 0.3 |
| Biol Psychiatry | 3 | 0.8 | J Neurol Neurosurg Psychiatry | 1 | 0.3 |
| Brain Behav | 3 | 0.8 | J Neuropsychol | 1 | 0.3 |
| Brain Lang | 3 | 0.8 | J Neurotrauma | 1 | 0.3 |
| Elife | 3 | 0.8 | J Orthop Sports Phys Ther | 1 | 0.3 |
| Eur Arch Psychiatry Clin Neurosci | 3 | 0.8 | J Physiol Anthropol | 1 | 0.3 |
| Neural Plast | 3 | 0.8 | J Psycholinguist Res | 1 | 0.3 |
| Psychopharmacology (Berl) | 3 | 0.8 | J Speech Lang Hear Res | 1 | 0.3 |
| Schizophr Res | 3 | 0.8 | J Vis Exp | 1 | 0.3 |
| Alcohol Alcohol | 2 | 0.5 | J Voice | 1 | 0.3 |
| Am J Psychiatry | 2 | 0.5 | JAMA Psychiatry | 1 | 0.3 |
| Bipolar Disord | 2 | 0.5 | Nat Commun | 1 | 0.3 |
| Brain Stimul | 2 | 0.5 | Neural Regen Res | 1 | 0.3 |
| Brain Topogr | 2 | 0.5 | Neurobiol Learn Mem | 1 | 0.3 |
| Brain | 2 | 0.5 | Neurodegener Dis | 1 | 0.3 |
| Clin Physiol Funct Imaging | 2 | 0.5 | Neurogastroenterol Motil | 1 | 0.3 |
| Depress Anxiety | 2 | 0.5 | Neurol Med Chir (Tokyo) | 1 | 0.3 |
| Dev Cogn Neurosci | 2 | 0.5 | Neurology | 1 | 0.3 |
| Drug Alcohol Depend | 2 | 0.5 | Neuropsychobiology | 1 | 0.3 |
| Exp Brain Res | 2 | 0.5 | Neuroradiology | 1 | 0.3 |
| Hippocampus | 2 | 0.5 | Nutr Neurosci | 1 | 0.3 |
| J Int Neuropsychol Soc | 2 | 0.5 | Obes Res Clin Pract | 1 | 0.3 |
| J Psychiatr Res | 2 | 0.5 | Physiol Rep | 1 | 0.3 |
| J Psychopharmacol | 2 | 0.5 | PLoS Biol | 1 | 0.3 |
| Mol Psychiatry | 2 | 0.5 | Proc IEEE Inst Electr Electron Eng | 1 | 0.3 |
| Neurobiol Aging | 2 | 0.5 | Psychiatry Clin Neurosci | 1 | 0.3 |
| Proc Natl Acad Sci USA | 2 | 0.5 | Psychophysiology | 1 | 0.3 |
| Prog Neuropsychopharmacol Biol Psychiatry | 2 | 0.5 | Res Dev Disabil | 1 | 0.3 |
| Psychoneuroendocrinology | 2 | 0.5 | Schizophr Bull | 1 | 0.3 |
| Acta Radiol | 1 | 0.3 | Swiss Med Wkly | 1 | 0.3 |
| Alcohol Clin Exp Res | 1 | 0.3 |
Thresholds of statistical significance used by the 338 surveyed studies reporting whole brain results.
| Inferential method | % | |
|---|---|---|
| Cluster-level inference ( | ||
| Corrected | 228 | 93.4 |
| Corrected | 1 | 0.4 |
| Corrected | 8 | 3.3 |
| Corrected | 7 | 2.9 |
| Voxel-level inference ( | ||
| Corrected | 67 | 94.4 |
| Corrected | 1 | 1.4 |
| Corrected | 1 | 1.4 |
| Corrected | 1 | 1.4 |
| Corrected | 1 | 1.4 |
| Threshold free cluster enhancement ( | ||
| Corrected | 7 | 100.0 |
| Uncorrected inference ( | ||
| 1 | 6.3 | |
| 1 | 6.3 | |
| 1 | 6.3 | |
| 1 | 6.3 | |
| 1 | 6.3 | |
| 4 | 25.0 | |
| 1 | 6.3 | |
| 3 | 18.8 | |
| 1 | 6.3 | |
| 2 | 12.5 |
Cross-tabulation of the theoretical methods and statistical thresholds of the 371 surveyed studies reporting corrected statistics.
| Inferential method | Theoretical method | Total count | ||||
|---|---|---|---|---|---|---|
| Parametric (FWE) | Parametric (FDR) | Parametric (Monte Carlo) | Permutation | Unknown | ||
| Voxelwise | 72 | 18 | 2 | 92 | ||
| Clusterwise | 155 | 12 | 92 | 6 | 5 | 270 |
| TFCE | 9 | 9 | ||||
Cluster-defining primary thresholds (CDTs) of 270 studies using clusterwise inferences.
| CDT ( | % | |
|---|---|---|
| 0.05 | 9 | 3.3 |
| 0.025 | 1 | 0.4 |
| 0.02 | 1 | 0.4 |
| 0.0125 | 1 | 0.4 |
| 0.01 | 60 | 22.2 |
| 0.005 | 49 | 18.1 |
| 0.001 | 124 | 45.9 |
| 0.0004 | 1 | 0.4 |
| 0.0001 | 2 | 0.7 |
| 0.00001 | 1 | 0.4 |
| Unknown | 21 | 7.8 |